Development of Resistance towards Artesunate in MDA-MB-231 Human Breast Cancer Cells

@inproceedings{Bachmeier2011DevelopmentOR,
  title={Development of Resistance towards Artesunate in MDA-MB-231 Human Breast Cancer Cells},
  author={Beatrice E Bachmeier and Iduna Fichtner and Peter H. Killian and Emanuel Kronski and Ulrich Pfeffer and Thomas H Efferth},
  booktitle={PloS one},
  year={2011}
}
Breast cancer is the most common cancer and the second leading cause of cancer death in industrialized countries. Systemic treatment of breast cancer is effective at the beginning of therapy. However, after a variable period of time, progression occurs due to therapy resistance. Artesunate, clinically used as anti-malarial agent, has recently revealed remarkable anti-tumor activity offering a role as novel candidate for cancer chemotherapy. We analyzed the anti-tumor effects of artesunate in… CONTINUE READING